Novo Nordisk (NYSE:NVO) Faces Challenges Amidst Strong Competition and Sales Slowdown
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameNovo Nordisk A/S
-
Registration countryDenmark
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









